These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21824090)

  • 1. Small molecule inhibitors of STAT3 for cancer therapy.
    Zhao M; Jiang B; Gao FH
    Curr Med Chem; 2011; 18(26):4012-8. PubMed ID: 21824090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
    Furtek SL; Backos DS; Matheson CJ; Reigan P
    ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.
    Gelain A; Mori M; Meneghetti F; Villa S
    Curr Med Chem; 2019; 26(27):5165-5206. PubMed ID: 30027840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.
    Huang W; Liu Y; Wang J; Yuan X; Jin HW; Zhang LR; Zhang JT; Liu ZM; Cui JR
    Eur J Med Chem; 2018 Sep; 157():887-897. PubMed ID: 30145375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting STAT3 in cancer: how successful are we?
    Yue P; Turkson J
    Expert Opin Investig Drugs; 2009 Jan; 18(1):45-56. PubMed ID: 19053881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel activators and small-molecule inhibitors of STAT3 in cancer.
    Yang L; Lin S; Xu L; Lin J; Zhao C; Huang X
    Cytokine Growth Factor Rev; 2019 Oct; 49():10-22. PubMed ID: 31677966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
    Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
    Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
    Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
    Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Activity of Novel Signal Transducer and Activator of Transcription 3 Inhibitors on Retinoblastoma.
    Jo DH; Lee S; Bak E; Cho CS; Han YT; Kim K; Suh YG; Kim JH
    Mol Pharmacol; 2021 Jul; 100(1):63-72. PubMed ID: 34016717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3: A Potential Drug Target for Tumor and Inflammation.
    Hu YS; Han X; Liu XH
    Curr Top Med Chem; 2019; 19(15):1305-1317. PubMed ID: 31218960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
    Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Ding N; Zhang W; Li Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
    Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
    PLoS One; 2017; 12(6):e0178844. PubMed ID: 28636670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
    Dong J; Cheng XD; Zhang WD; Qin JJ
    J Med Chem; 2021 Jul; 64(13):8884-8915. PubMed ID: 34170703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
    Zhang L; Peterson TE; Lu VM; Parney IF; Daniels DJ
    PLoS One; 2019; 14(7):e0220569. PubMed ID: 31361777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report.
    Haftchenary S; Avadisian M; Gunning PT
    Anticancer Drugs; 2011 Feb; 22(2):115-27. PubMed ID: 21063201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Li Y
    Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors.
    Mankan AK; Greten FR
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1263-75. PubMed ID: 21751940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review).
    Wang X; Crowe PJ; Goldstein D; Yang JL
    Int J Oncol; 2012 Oct; 41(4):1181-91. PubMed ID: 22842992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.